Elsevier’s ClinicalPath places evidence-based oncology pathways and clinical trial support within the workflow to empower patient-centered treatment decisions for optimal patient outcomes. Developed by a national committee of academic and community oncologists, our pathways cover over 95% of the most common cancer cases in medical and radiation oncology.

ClinicalPath empowers clinicians to deliver optimal patient care:

  • Standardize care: Supports standardization of care among physicians in an increasingly complex field.

  • Provide evidence: Guides oncologists in their treatment decisions, based on the latest evidence-based research.

  • Prioritize clinical trials: Promotes accrual to clinical trials, with trials prioritized within each pathway. Complete the form to learn more about ClinicalPath.